Envista Holdings Corp. (NVST) News

Envista Holdings Corp. (NVST): $38.25

-0.84 (-2.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter NVST News Items

NVST News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

NVST News Highlights

  • For NVST, its 30 day story count is now at 24.
  • Over the past 23 days, the trend for NVST's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • BEAT, PDS and DUO are the most mentioned tickers in articles about NVST.

Latest NVST News From Around the Web

Below are the latest news stories about Envista Holdings Corp that investors may wish to consider to help them evaluate NVST as an investment opportunity.

Envista Announces Participation in Jefferies Virtual Dental Summit

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Jefferies Virtual Dental Summit on Thursday, February 24th from 6:00 – 6:45 AM PST.

Yahoo | February 23, 2022

Charles River (CRL) DSA Arm Sees Growth, Cell Supply Sluggish

The acquisitions of Cognate BioServices and Vigene Biosciences contribute to the growth of Charles River's (CRL) Manufacturing Solutions arm.

Yahoo | February 22, 2022

Henry Schein (HSIC) Up 10.1% Since Posting Q4 Earnings Beat

Henry Schein (HSIC) stock rallies on strong fourth-quarter performance and bullish 2022 EPS guidance.

Yahoo | February 21, 2022

Syneos Health (SYNH) Q4 Earnings Top Estimates, Margins Down

Syneos Health (SYNH) reports better-than-expected earnings for the fourth quarter and strong performances by the Clinical Solutions and Commercial Solutions arms.

Yahoo | February 18, 2022

Globus Medical (GMED) Q4 Earnings Top Estimates, Gross Margin Up

Strength in Musculoskeletal Solutions and Enabling Technologies products drove Globus Medical's (GMED) Q4 revenues.

Yahoo | February 18, 2022

Is Indivior PLC (INVVY) Outperforming Other Medical Stocks This Year?

Here is how Indivior PLC (INVVY) and Envista (NVST) have performed compared to their sector so far this year.

Yahoo | February 17, 2022

Henry Schein (HSIC) Q4 Earnings Top Estimates, Margins Grow

Robust performances by all three operating businesses drove Henry Schein's (HSIC) Q4 revenues.

Yahoo | February 15, 2022

Omnicell (OMCL) Q4 Earnings Miss Estimates, Revenues Beat

Robust performance by the Product and Service segments is driving Omnicell's (OMCL) fourth-quarter top line.

Yahoo | February 15, 2022

Envista Holdings Corporation's (NVST) CEO Amir Aghdaei on Q4 2021 Results - Earnings Call Transcript

Envista Holdings Corporation (NVST) Q4 2021 Earnings Conference Call February 09, 2022 5:00 PM ET Company Participants Stephen Keller – Vice President of Investor Relations Amir Aghdaei – President and Chief Executive Officer Howard Yu – Chief Financial Officer Conference Call Participants Elizabeth Anderson – Evercore Jeff Johnson – Baird...

SA Transcripts on Seeking Alpha | February 10, 2022

Dermata, Innoviva top healthcare gainers; while InfuSystem, Seagen lead losers pack

Gainers: Dermata Therapeutics DRMA +35%. Innoviva (INVA) +11%. Mainz Biomed (MYNZ) +9%. Regional Health Properties RHE +9%. Envista Holdings (NVST) +8%.Losers: InfuSystem

Seeking Alpha | February 10, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4883 seconds.